Andexanet alfa for reversal of factor Xa inhibitors.

In a new study published in the New England Journal of Medicine, researchers evaluated 352 patients (mean age 77 years) with acute major bleeding within 18 hours after administration of a bolus of andexanet, followed by a 2-hour infusion. Bleeding was predominantly...